Ginkgo biloba in Alzheimer's disease: A systematic review

Wiener Medizinische Wochenschrift

Volumn 160, Issue 21-22, 2010, Pages 539-546

  Janßen, Inger M ^a   Sturtz, Sibylle ^a   Skipka, Guido ^a   Zentner, Annette ^b   Garrido, Marcial V ^b   Busse, Reinhard ^b  

^a INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE IQWIG   (Germany)

^b TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Alzheimer's disease; Anti dementia drugs; EGb 761; Ginkgo biloba; systematic review

Indexed keywords

GINKGO BILOBA EXTRACT; NOOTROPIC AGENT; PLACEBO;

ALZHEIMER DISEASE; BIBLIOGRAPHIC DATABASE; COGNITION; DAILY LIFE ACTIVITY; DEPRESSION; DRUG MEGADOSE; DRUG WITHDRAWAL; FOLLOW UP; GINKGO BILOBA; HUMAN; LOW DRUG DOSE; MENTAL DISEASE; OUTCOME ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ALZHEIMER DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NOOTROPIC AGENTS; PHYTOTHERAPY; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 78651403546     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-010-0844-8     Document Type: Review

References (23)

1. Deutsche Gesellschaft für Neurologie, Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde. S3-Leitlinie "Demenzen": Langversion (Online). 23.11.2009 (Cited 27.09.2010). URL: http://www.dgppn.de/fileadmin/user-upload/-medien/download/pdf/ kurzversion-leitlinien/s3-leitlinie-demenz-kf.pdf
2. Institute for Quality and Efficiency in Health Care. General methods: version 3.0 (Online). 19.12.2008 (Cited 01.07.2010). URL: http://www.iqwig.de/ download/Methoden-IQWiG-V-2-0.pdf
3. Institute for Quality and Efficiency in Health Care. Ginkgohaltige Präparate bei Alzheimer Demenz: Abschlussbericht; Auftrag A05-19B; Version 1.0 (Online). 29.09.2008 (Cited 17.10.2008). URL: http://www.iqwig.de/download/ A05-19B-Abschlussbericht-Ginkgohaltige-Praeparate-bei-Alzheimer-Demenz.pdf
4. JP Higgins SG Thompson JJ Deeks, et al. 2003 Measuring inconsistency in meta-analyses BMJ 327 7414 557 560 10.1136/bmj.327.7414.557 12958120
5. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 3 177 188 1:STN:280:DyaL2s7gsVamtA%3D%3D 10.1016/0197-2456(86)90046-2 3802833
6. S Yancheva R Ihl G Nikolova, et al. 2009 Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial Aging Ment Health 13 2 183 190 1:STN:280:DC%2BD1M3lvFyluw%3D%3D 10.1080/ 13607860902749057 19347685
7. R McCarney P Fisher S Iliffe, et al. 2008 Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial Int J Geriatr Psychiatry 23 12 1222 1230 10.1002/gps.2055 18537221
8. Dr. Willmar Schwabe Arzneimittel. Randomised, double-blind, placebo-controlled, parallel-group, multicentre trial to confirm the efficacy, safety and tolerability of a once-daily formulation of ginkgo biloba special extract EGb 761 in patients suffering from Alzheimer's disease or vascular dementia, both associated with neuropsychiatric symptoms: clinical and biometrical study report: study-no. 523001.01.075 (unpublished). 2008
9. S Kanowski WM Herrmann K Stephan, et al. 1996 Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia Pharmacopsychiatry 29 2 47 56 1:STN:280:DyaK283pvVSrsg%3D%3D 10.1055/s-2007-979544 8741021
10. O Napryeyenko I Borzenko 2007 Ginkgo biloba special extract in dementia with neuropsychiatric features: a randomised, placebo-controlled, double-blind clinical trial Arzneimittelforschung 57 1 4 11 1:CAS:528:DC%2BD2sXitl2nsbY%3D 17341003
11. LS Schneider ST DeKosky MR Farlow, et al. 2005 A randomized, double-blind, placebo-controlled trial of two doses of ginkgo biloba extract in dementia of the Alzheimer's type Curr Alzheimer Res 2 5 541 551 1:CAS:528:DC%2BD2MXht1CgtLrN 10.2174/156720505774932287 16375657
12. PL Le Bars MM Katz N Berman, et al. 1997 A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia JAMA 278 16 1327 1332 1:CAS:528:DyaK2sXntVakur0%3D 10.1001/jama.278.16.1327 9343463
13. Birks J, Grimley EV, Van Dongen M. Ginkgo biloba for cognitive impairment and dementias. Cochrane Database Syst Rev, 2009(4): CD003120
14. B Diamond S Johnson K Torsney, et al. 2003 Complementary and alternative medicines in the treatment of dementia: an evidence-based review Drugs Aging 20 13 981 998 1:CAS:528:DC%2BD3sXps1Kmt7s%3D 10.2165/00002512-200320130-00003 14561102
15. KM Langa NL Foster EB Larson 2004 Mixed dementia: emerging concepts and therapeutic implications JAMA 292 23 2901 2908 1:CAS:528:DC%2BD2cXhtFajsrfO 10.1001/jama.292.23.2901 15598922
16. U Werneke T Turner S Priebe 2006 Complementary medicines in psychiatry: review of effectiveness and safety Br J Psychiatry 188 2 109 121 10.1192/bjp.188.2.109 16449696
17. T Gabryelewicz M Barcikowska DL Jarczewska 2005 Alzheimer's disease therapy: theory and practice (Polish) Wiad Lek 58 9-10 528 535 16529064
18. Birks J, Evans JG. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev, 2009(1): CD003120
19. S Weinmann S Roll C Schwarzbach, et al. 2010 Effects of Ginkgo biloba in dementia: systematic review and meta-analysis BMC Geriatr 10 14 10.1186/1471-2318-10-14 20236541
20. Schwabe U. Antidementiva. In: Schwabe U, Paffrath D (ed) Arzneiverordnungsreport 2007. Springer, Heidelberg, pp. 313-326, 2008
21. Institute for Quality and Efficiency in Health Care. Cholinesterasehemmer bei Alzheimer Demenz: Abschlussbericht; Auftrag A05-19A (Online). 07.02.2007 (Cited 17.07.2008). URL: http://www.iqwig.de/download/A05-19A-Abschlussbericht- Cholinesterasehemmer-bei-Alzheimer-Demenz.pdf
22. HH Dodge T Zitzelberger BS Oken, et al. 2008 A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline Neurology 70 19 Pt 2 1809 1817 1:STN:280:DC%2BD1c3psFSitg%3D%3D 18305231
23. FJ Molnar M Man-Son-Hing D Fergusson 2009 Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia J Am Geriatr Soc 57 3 536 546 10.1111/j.1532-5415.2008.02122.x 19187414